21 results on '"Watt, A. D."'
Search Results
2. Defining an approach for therapeutic strategies in metabolic dysfunction–associated steatotic liver disease after liver transplantation
3. Navigating the ‘Specific Etiology’ steatohepatitis category: Evaluation & management of non-alcohol/non-metabolic dysfunction-associated steatohepatitis
4. Obesity management for the hepatologist – what to do, how to do it and why
5. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
6. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis
7. Multicenter Experience Using Simeprevir and Sofosbuvir With or Without Ribavirin to Treat Hepatitis C Genotype 1 After Liver Transplant
8. REPLY
9. The use of simeprevir and sofosbuvir to treat HCV G1 in the Liver Transplant Setting: The experience in 3 US Centers: 19
10. Multicenter Experience using Sofosbuvir and Simeprevir with/without Ribavirin to Treat HCV Genotype 1 after Liver Transplantation: 9
11. De Novo Colorectal and Pancreatic Cancer in Liver‐Transplant Recipients: Identifying the Higher‐Risk Populations
12. Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underused Potential
13. Nutritional status amongst patients with alcoholic cirrhosis undergoing liver transplantation: trends over time and impact on post-transplant graft and patient survival: 1706
14. New Insights Into Toxicity and Pharmacokinetics of Ribavirin and Cyclosporine in Liver Transplant Recipients on Boceprevir-Based Antiviral Therapy - Evidence of Need for New Target Troughs for CsA and lower Dosing of Ribavirin: 209
15. Recipient but not Donor PNPLA3 and IL28B Genotype are Important Determinants of Posttransplant Diabetes and Obesity: 5
16. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis
17. Sarcopenia in Cirrhosis: Looking Beyond the Skeletal Muscle Loss to See the Systemic Disease
18. Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander
19. Reply
20. Long‐term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy
21. Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.